HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Henry Gomez Selected Research

Epirubicin (Ellence)

2/2017RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Henry Gomez Research Topics

Disease

19Breast Neoplasms (Breast Cancer)
01/2022 - 03/2007
10Neoplasms (Cancer)
01/2022 - 03/2009
5Pathologic Complete Response
10/2021 - 11/2010
5Triple Negative Breast Neoplasms
10/2021 - 07/2012
3Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2013 - 10/2009
2Cardiotoxicity
01/2020 - 07/2012
2Neutropenia
06/2013 - 07/2012
2Thrombocytopenia (Thrombopenia)
03/2013 - 07/2012
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Melanoma (Melanoma, Malignant)
10/2021
1Diabetes Mellitus
01/2020
1Gallbladder Neoplasms (Gallbladder Cancer)
01/2019
1Exanthema (Rash)
01/2016
1Infertility (Sterility)
02/2014
1Eczema
01/2014
1Diarrhea
06/2013
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
03/2013
1Anemia
03/2013
1Fatigue
03/2013
1Lymphopenia (Lymphocytopenia)
03/2013
1Nausea
03/2013
1T-Cell Lymphoma (Lymphoma, T Cell)
03/2013
1Myalgia
03/2013
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2011
1Lymphoma (Lymphomas)
10/2009
1Adenocarcinoma
03/2009
1Obesity
03/2009

Drug/Important Bio-Agent (IBA)

7Trastuzumab (Herceptin)FDA Link
11/2021 - 05/2010
7Lapatinib (GW572016)FDA Link
10/2021 - 05/2010
4human ERBB2 proteinIBA
02/2017 - 05/2010
3Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2020
3Estrogen ReceptorsIBA
10/2021 - 05/2011
3Hormones (Hormone)IBA
10/2021 - 03/2008
3AnthracyclinesIBA
12/2017 - 05/2011
3Paclitaxel (Taxol)FDA LinkGeneric
02/2017 - 11/2010
3ErbB Receptors (EGF Receptor)IBA
04/2016 - 05/2010
2Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 11/2010
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 07/2012
2Phosphotransferases (Kinase)IBA
01/2018 - 05/2010
2Fluorouracil (Carac)FDA LinkGeneric
02/2017 - 11/2010
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2017 - 11/2010
2Capecitabine (Xeloda)FDA Link
07/2013 - 05/2010
2taxaneIBA
05/2011 - 01/2010
1Biosimilar PharmaceuticalsIBA
01/2022
1Biological ProductsIBA
01/2022
1Tumor Biomarkers (Tumor Markers)IBA
10/2021
1HLA-DR Antigens (HLA-DR)IBA
10/2021
1durvalumabIBA
10/2021
1pembrolizumabIBA
10/2021
1ParaffinIBA
01/2019
1CarcinogensIBA
01/2019
1Formaldehyde (Formol)FDA Link
01/2019
1Estrogens (Estrogen)FDA Link
01/2018
1PhosphoproteinsIBA
01/2018
1Taxoids (Taxanes)IBA
12/2017
1Epirubicin (Ellence)FDA LinkGeneric
02/2017
1Epidermal Growth Factor (EGF)IBA
04/2016
1Ointments (Pastes)IBA
01/2014
1Sorafenib (BAY 43-9006)FDA Link
07/2013
1plitidepsin (aplidine)IBA
03/2013
1Transaminases (Aminotransferases)IBA
03/2013
1Creatine Kinase (Creatine Phosphokinase)IBA
03/2013
1Nucleic AcidsIBA
07/2012
1Mitoxantrone (Novantrone)FDA LinkGeneric
07/2012
1IfosfamideFDA LinkGeneric
07/2012
1Etoposide (VP 16)FDA LinkGeneric
07/2012
1Pharmaceutical PreparationsIBA
07/2012
1AnthraquinonesIBA
07/2012
1Investigational DrugsIBA
07/2012
1pixantrone (BBR 2778)IBA
07/2012
1GemcitabineFDA Link
07/2012
1Vinorelbine (Navelbine)FDA LinkGeneric
07/2012
1Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2012
1Rituximab (Mabthera)FDA Link
07/2011
1Tyrosine Kinase InhibitorsIBA
05/2010
1ixabepilone (BMS 247550)FDA Link
01/2010
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2009
1Methotrexate (Mexate)FDA LinkGeneric
10/2009
1exemestane (Aromasin)FDA Link
03/2008
1Celecoxib (Celebrex)FDA Link
03/2008
1TamoxifenFDA LinkGeneric
03/2008
1Messenger RNA (mRNA)IBA
03/2007

Therapy/Procedure

11Therapeutics
01/2022 - 01/2010
7Drug Therapy (Chemotherapy)
12/2017 - 10/2009
3Neoadjuvant Therapy
10/2021 - 05/2011
1Immunotherapy
10/2021
1Adjuvant Chemotherapy
01/2020
1Intravenous Infusions
03/2013
1Salvage Therapy
07/2012
1Combination Drug Therapy (Combination Chemotherapy)
10/2009
1Pancreatectomy
03/2009
1Aftercare (After-Treatment)
03/2008